When Sydney tech entrepreneur Paul Conyngham learned that his dog Rosie had an aggressive form of cancer, the prognosis was grim. Like many pet owners facing that moment, he searched desperately for options. But instead of accepting defeat, Conyngham tried something unusual: he turned to artificial intelligence.

Using tools like ChatGPT alongside advanced protein-modeling systems such as AlphaFold, he began analyzing Rosie’s tumor DNA. What followed was an unexpected collaboration between technology, researchers, and veterinarians — one that may point to the future of personalized medicine.

1. The Diagnosis That Started Everything

Rosie was diagnosed with a highly aggressive cancer. Traditional treatment options offered limited hope. Determined to explore every possibility, Conyngham decided to sequence the tumor’s dna through a laboratory at the university of New South Wales, a process that reportedly cost around $3,000.

The sequencing data revealed the genetic mutations driving the tumor.

2. Where AI Entered the Picture

With the raw genetic data in hand, Conyngham used AI tools to help interpret it. ChatGPT was used to brainstorm potential approaches and analyze complex biological information, while AlphaFold helped predict protein structures related to the mutations.

The goal was ambitious: design a customized mRNA vaccine that could train Rosie’s immune system to target the cancer.

3. Scientists Turned the idea Into Reality

This wasn’t a solo experiment. Researchers and specialists worked alongside the AI-assisted analysis to refine the concept and produce the vaccine. Scientists ultimately created the personalized mRNA treatment and administered it in late 2025.

The collaboration between AI insights and human expertise made the project possible.

4. A Remarkable Early Result

Within months, Rosie’s tumors reportedly shrank by about 75 percent. Even more importantly, her quality of life improved — she became more active and visibly healthier.

While still an early and experimental case, the outcome has captured attention across scientific and tech communities.

5. Why This Matters

Experts emphadata-size that AI did not “cure cancer” on its own. Veterinarians, geneticists, and researchers handled the diagnosis, treatment, and clinical decisions.

But tools like ChatGPT helped accelerate the analysis and brainstorming process.

And that hints at something bigger: a future where AI works alongside scientists to design highly personalized treatments — not just for pets, but potentially for humans as well.